Ketorolac

• CAT Number: A000614
• CAS Number: 74103-07-4
• Molecular Formula: C15H12NO3 • C4H12NO3
• Molecular Weight: 376.40
• Purity: ≥95%
• Target: COX
• Solubility: Soluble in DMSO > 10 mM
• Storage: -20 ℃
• IUPAC Name: 2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
• InChI: InChI=1S/C15H13NO3.C4H11NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13;5-4(1-6,2-7)3-8/h1-7,11H,8-9H2,(H,18,19);6-8H,1-3,5H2
• InChIKey: BWHLPLXXIDYSNW-UHFFFAOYSA-N
• SMILES: C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O

Ketorolac（Cat No.:A000614）is a nonsteroidal anti-inflammatory drug (NSAID) used for the short-term management of moderate to severe pain. It works by inhibiting the cyclooxygenase (COX) enzymes, reducing the synthesis of prostaglandins that cause inflammation and pain. Ketorolac is administered orally, intravenously, or as an eye drop. It is commonly used postoperatively to manage pain and reduce the need for opioids. Due to its potency, treatment duration is typically limited to five days to minimize risks of gastrointestinal bleeding, renal impairment, and cardiovascular events. Ketorolac is valued for its strong analgesic properties in acute pain management.